bih.button.backtotop.text
BROWSE BY TEST NAME
%
1
2
3
5
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Clear
 
Test Code:
090-31-0530-01

Order Name:
HSV IgM **

 
Useful For:
Screening, aiding in the diagnosis of infection with herpes simplex virus. May be used as an aid for detection of recent herpes simplex virus (HSV) infection. The preferred testing method for diagnosis of active HSV infection is Polymerase chain reaction of a dermal swab of a suspicious lesion.
This assay does not distinguish between HSV-1 and HSV-2 IgM antibodies.
 
Methodology:
IFA (Indirect immunofluorescence assay)
 
AliasesName:
Herpes Simplex Virus Antibodies, IgM
Herpes Simplex Virus Ab Type I&II, IgM
HSV type 1&2 Ab, IgM
 
 
 
Test Code:
090-31-0530-01

Order Name:
HSV IgM **

 
Collection Specimen Or Container:
Blood/ Plain blood (Red top) 6 mL, 1 tube
 
Specimen Testing Type:
Serum, minimum volume 1 mL
 
Sub Mission Container:
Plastic tube
 
Specimen Stabillity:
Specimen Type : Temperature/Time :
 
 
 
Test Code:
090-31-0530-01

Order Name:
HSV IgM **

 
Method detail:
IFA (Indirect immunofluorescence assay)
 
Schedule:
N/A **Sent out to BPL, Bangkok Pathology-Laboratory
 
Turnaround Time:
Reported within 3 days 
 
Performing Location:
BPL, Bangkok Pathology-Laboratory
Referral Lab Services, Laboratory Department 14160-2
 
 
 
Test Code:
090-31-0530-01

Order Name:
HSV IgM **

 
 
Clinical Information:
Herpes simplex virus (HSV) types 1&2 are members of the Herpesviridae family, and produce infections that may range from mild stomatitis to disseminated and fatal disease. Clinical conditions associated with HSV infection include gingivostomatitis, keratitis, encephalitis, vesicular skin eruptions, aseptic meningitis, neonatal herpes, genital tract infections, and disseminated primary infection.
 
Reference Value:
Negative ( < 1:10 )
 
Interpretation:
This assay detects IgM antibodies to herpes simplex virus (HSV), and cannot differentiate types 1 and 2.
The presence of IgM antibodies to HSV types 1&2 indicates recent infection, but negative result does not necessarily rule out a primary or reactivated infection since specimens may have been collected too early in the course of disease, when antibodies have not yet reached detectable levels, or too late, after IgM levels have declined below detectable levels.
 
Clinical Reference:
BPL Service Catalog 2016
www.mayomedicallaboratories.com (Retrieved: 18 Jan 2019)